SLC25A15P4

Across TCGA pan-cancer cohorts, SLC25A15P4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SLC25A15P4 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher SLC25A15P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC25A15P4 expression acts as an unfavorable survival marker, although some lineages such as TGCT show a favorable association.

MESO, COAD, and BLCA are the cancer types where SLC25A15P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.052	0.567	<.001	108	view →
COAD	DFS	Tertile	IV	0.159	0.503	.006	54	view →
BLCA	DFS	Tertile	All	0.237	0.519	.010	45	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
KIRC	DFS	Tertile	II,III,IV	0.195	0.506	.038	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	36	view →
LIHC	DFS	Tertile	All	0.207	0.548	.001	36	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
SARC	OS	Tertile	All	0.334	0.750	.001	18	view →
TGCT	DFS	Median	All	0.877	0.717	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SLC25A15P4–MESO (OS)

Open the MESO breakdown →